Sharps Technology Inc.

NASDAQ: STSS · Real-Time Price · USD
3.86
-0.19 (-4.69%)
At close: May 27, 2025, 3:26 PM

Company Description

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.

It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.

The company was incorporated in 2017 and is based in Melville, New York.

Sharps Technology Inc.
Sharps Technology Inc. logo
Country United States
IPO Date Apr 14, 2022
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 55
CEO Robert M. Hayes

Contact Details

Address:
105 Maxess Road
Melville, New York
United States
Website https://sharpstechnology.com

Stock Details

Ticker Symbol STSS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001737995
CUSIP Number 82003F309
ISIN Number US82003F1012
Employer ID 82-3751728
SIC Code 3841

Key Executives

Name Position
Robert M. Hayes Chief Executive Officer & Director
Andrew R. Crescenzo CPA Chief Financial Officer
Frank Parrado Corporate Controller

Latest SEC Filings

Date Type Title
May 22, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G Filing
May 15, 2025 10-Q Quarterly Report
May 07, 2025 SCHEDULE 13G Filing
May 07, 2025 8-K Current Report
May 06, 2025 4 Filing
May 06, 2025 3 Filing
May 06, 2025 8-K Current Report
Apr 30, 2025 8-K Current Report
Apr 30, 2025 8-K Current Report